Home > Riviste > Italian Journal of Dermatology and Venereology > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2020 October;155(5) > Giornale Italiano di Dermatologia e Venereologia 2020 October;155(5):602-21



Opzioni di pubblicazione
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo


REVIEW   Free accessfree

Giornale Italiano di Dermatologia e Venereologia 2020 October;155(5):602-21

DOI: 10.23736/S0392-0488.20.06698-5


lingua: Inglese

Skin tests in the diagnosis of adverse drug reactions

Luca STINGENI 1, Leonardo BIANCHI 1 , Marta TRAMONTANA 1, Paolo D. PIGATTO 2, Cataldo PATRUNO 3, Monica CORAZZA 4, Caterina FOTI 5, Gabriella FABBROCINI 6, Giuseppe MICALI 7, Paolo ROMITA 5, Maddalena NAPOLITANO 8, Katharina HANSEL 1

1 Section of Dermatology, Department of Medicine, University of Perugia, Perugia, Italy; 2 Unit of Clinical Dermatology, Department of Biomedical, Surgical and Dental Sciences, IRCCS Galeazzi Orthopedic Institute, University of Milan, Milan, Italy; 3 Section of Dermatology, Department of Health Sciences, Magna Graecia University, Catanzaro, Italy; 4 Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy; 5 Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, Bari, Italy; 6 Department of Dermatology, Federico II University, Naples, Italy; 7 Dermatology Clinic, P.O.G. Rodolico, Vittorio Emanuele Polyclinic, Catania, Italy; 8 Vincenzo Tiberio Department of Health Sciences, University of Molise, Campobasso, Italy

Adverse drug reactions (ADRs) are common and influence negatively the patient’s therapeutic options. They recognize multiple pathogenic mechanisms, some of immunological origin, and the clinical manifestations involve several organs and systems, including skin and/or mucous membranes in 25-30% of patients. The identification of the trigger drug remains a medical challenge, mainly in poly-medicated patients. Anamnesis and clinical approach are crucial, but allergy work-up is the essential tool to confirm or exclude the causative role of the culprit drug. Besides in-vitro tests and drug provocation test, skin tests (ST) represent the cornerstone: patch test in delayed ADR, prick test in immediate ADR, and intradermal test in both. Nevertheless, ST are in continuous evolution and characterized by technical difficulties (concentration and vehicle) that can influence their value and specificity. In this article we review the indications and the rules in performing patch test, prick test, and intradermal test with the most commonly used drugs in Italy to determine the cause of a cutaneous and/or mucous ADR, precise the involved pathogenic mechanism, and provide a valid therapeutic alternative to the patient.

KEY WORDS: Drug-related side effects and adverse reactions; Patch tests; Intradermal tests; Skin tests; Review

inizio pagina